Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medicenna Therapeutics Corp (OP:MDNAF)

1.100 +0.340 (+44.74%)
Streaming Delayed Price Updated: 3:57 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 577,403
Open 0.8000
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.7600
Today's Range 0.7949 - 1.100
52wk Range 0.5732 - 1.891
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Therapeutics Announces Participation in Upcoming Conferences
From Medicenna Therapeutics Corp.
Via GlobeNewswire

Performance

YTD
-1.3%
-1.3%
1 Month
+61.5%
+61.5%
3 Month
+87.3%
+87.3%
6 Month
+33.3%
+33.3%
1 Year
-35.2%
-35.2%

More News

Read More
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Announces Results of Annual Meeting of Shareholders
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
Via Stocktwits
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
From Medicenna Therapeutics Corp.
Via GlobeNewswire
OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX
From OTC Markets
Via GlobeNewswire

Frequently Asked Questions

Is Medicenna Therapeutics Corp publicly traded?
Yes, Medicenna Therapeutics Corp is publicly traded.
What exchange does Medicenna Therapeutics Corp trade on?
Medicenna Therapeutics Corp trades on the OTC Traded
What is the ticker symbol for Medicenna Therapeutics Corp?
The ticker symbol for Medicenna Therapeutics Corp is MDNAF on the OTC Traded
What is the current price of Medicenna Therapeutics Corp?
The current price of Medicenna Therapeutics Corp is 1.100
When was Medicenna Therapeutics Corp last traded?
The last trade of Medicenna Therapeutics Corp was at 10/24/25 03:57 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.